References and Notes
<A NAME="RW20307ST-1">1</A>
Shankaran K.
Donnelly KL.
Shah SK.
Guthikonda RN.
MacCoss M.
Humes JL.
Pacholok SG.
Grant SK.
Kelly TM.
Wong KK.
Bioorg. Med. Chem. Lett.
2004,
14:
4539
<A NAME="RW20307ST-2">2</A>
Heinelt U.
Schultheis D.
Jaeger S.
Lindenmaier M.
Pollex A.
Beckmann HSG.
Tetrahedron
2004,
60:
9883
<A NAME="RW20307ST-3A">3a</A>
Zhou H.-B.
Dong C.
Alper H.
Chem. Eur. J.
2004,
10:
6058
<A NAME="RW20307ST-3B">3b</A>
Sommen GL.
Linden A.
Heimgartner H.
Eur. J. Org. Chem.
2005,
65:
3128
<A NAME="RW20307ST-3C">3c</A>
Kim TH.
Lee N.
Lee G.-J.
Kim JN.
Tetrahedron
2001,
57:
7134
<A NAME="RW20307ST-3D">3d</A>
Butler DCD.
Inman GA.
Alper H.
J. Org. Chem.
2000,
65:
5887
<A NAME="RW20307ST-3E">3e</A>
Ryoki N.
Takahiro N.
Yoshitaka N.
Sachiko O.
Akira N.
Haruo M.
Chem. Ber.
1989,
122:
2407
<A NAME="RW20307ST-4">4</A>
Baeg J.-O.
Bensimon C.
Alper H.
J. Am. Chem. Soc.
1995,
117:
4700
<A NAME="RW20307ST-5">5</A>
Baeg J.-O.
Alper H.
J. Am. Chem. Soc.
1994,
116:
1220
<A NAME="RW20307ST-6">6</A>
Yu C.
Dai X.
Su W.
Synlett
2007,
4:
646
<A NAME="RW20307ST-7">7</A>
Salehi P.
Khodaei MM.
Zolfigol MA.
Keyvan A.
Synth. Commun.
2003,
33:
3041
<A NAME="RW20307ST-8">8</A>
Marco B.
Roberto B.
Franca B.
Raimondo M.
Mauro P.
Giovanni P.
Giovanni S.
J. Org. Chem.
1999,
64:
1029
<A NAME="RW20307ST-9">9</A>
Vassilev GN.
Vassilev NG.
Oxid. Commun.
2002,
25:
608
<A NAME="RW20307ST-10">10</A>
HPLC conditions: DAICEL CHIRALCELOD-H-4.6 × 250 mm, hexane-i-PrOH-Et2NH = 90:10:1 (% v/v/v), 236 nm, 0.8 mL/min, 30 °C.
<A NAME="RW20307ST-11">11</A>
Typical Experimental Procedure for Cyclization of Thioureas with Epoxides
Thiourea 2 (5 mmol) was added to a stirred mixture of DMF (20 mL) and epoxide 1. The reaction was monitored by TLC until completion. The temperature of this reaction
was kept at 70 °C (or r.t.) for 72 h, then the solvent was removed by distillation
at reduced pressure. The residual was purified on silica gel (PE-EtOAc-CH2Cl2 = 10:1:1) to give thiazolindinimes 3 as white crystals.
Spectral data for obtained compounds:
(3-Phenyl-2-(phenylimino)thiazolidin-5-yl)methanol (3a)
White crystalline solid; mp 86.0-88.0 °C. ESI-MS: m/z (%) = 282.9 (70), 163.8 (100), 117.9 (56). Anal. Calcd for C16H16N2OS: C, 67.58; H, 5.67; N, 9.85; Found: C, 67.50; H, 5.78; N, 9.79. IR (KBr): νmax = 3274, 1645, 1595, 1529 cm-1. 1H NMR (400 MHz, CDCl3,): δ = 2.13 (dd, 1 H, J
1
= 5.6 Hz, J
2
= 1.2 Hz), 2.46 (d, 1 H, J = 6.4 Hz,), 3.20 (m, 1 H), 3.84 (q, 1 H, J = 7.2 Hz), 3.98 (q, 1 H, J = 5.6 Hz), 6.16 (s, 1 H), 6.98-7.53 (m, 10 H). 13C NMR (100 MHz, CDCl3): δ = 24.5, 32.0, 55.2, 119.3 (2 × CH), 123.0, 128.5, 128.7 (2 × CH), 130.4 (4 ×
CH), 138.4, 141.0, 153.9.
(3-Butyl-2-(phenylimino) thiazolidin-5-yl)methanol (3h)
White crystalline solid; mp: 69.4-71.5 °C. MS (EI): m/z (%) = 265 (4) [M+ + 1], 231 (85), 132 (65), 106 (100). Anal. Calcd for C14H20N2OS: C, 63.60; H, 7.62; N, 10.60. Found: C, 63.51; H, 7.81; N, 10.52. IR (KBr): νmax = 3355, 2949, 1639, 1510 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.87 (t, 3 H, J = 7.2 Hz), 1.24 (m, 2 H), 1.40 (m, 2 H,), 2.07 (d, 1 H, J = 5.2 Hz), 2.41 (d, 1 H, J = 5.6 Hz), 3.16 (m, 3 H), 3.68 (m, 1 H), 3.98 (q, 1 H, J = 5.2 Hz), 4.25 (s, 1 H), 7.26-7.47 (m, 5 H). 13C NMR (100 MHz, CDCl3): δ = 13.5, 19.7, 24.4, 32.0, 32.1, 40.2, 54.9, 127.7 (2 × CH), 128.5, 129.9 (2 ×
CH), 141.5, 156.6.